ADC Capacity Updates

  1. Simtra BioPharma Solutions Capacity Update October 2025: ADC 8/7/2025

    MilliporeSigma and Simtra's streamlined collaboration encompasses every stage, including bioconjugation, linker and payload supplies, formulation development, and final fill/finish of drug substance.

  2. MilliporeSigma Capacity Update October 2025: ADC 7/28/2025

    MilliporeSigma and Simtra's streamlined collaboration encompasses every stage, including bioconjugation, linker and payload supplies, formulation development, and final fill/finish of drug substance.

  3. Integrated ADC Offering: From Concept To Commercialization 7/28/2025

    Leveraging deep ADC expertise and experience, successfully develop high quality, commercially viable processes, spanning from pre-clinical development through commercial scale manufacturing.

  4. AGC Biologics Capacity Update April 2025: ADC 4/21/2025

    This presentation offers a global overview of our comprehensive ADC program, providing developers with full end-to-end support — all under a single, streamlined contract.

  5. Simtra Biopharma Solutions Capacity Update April 2025: ADC 4/21/2025

    Witness how proven expertise and expanding capabilities in ADC manufacturing can help you scale high-value injectable therapies with speed, quality, and regulatory confidence.

  6. Abzena Capacity Update April 2025: ADC 4/21/2025

    Our integrated expertise can help you develop and manufacture dual payload ADCs with optimized efficacy, precision conjugation, and scalable solutions.

  7. Aragen Bioscience, Inc. Capacity Update April 2025: ADC 4/21/2025

    Discover how our end-to-end ADC solutions — from advanced conjugation technologies to scalable manufacturing — can accelerate your therapeutic development.